世界の直接的レニン阻害剤市場予測2023-2029:アリスキレン、レミキレン、その他

【英語タイトル】Direct Renin Inhibitors Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23LY8470)・商品コード:MMG23LY8470
・発行会社(調査会社):Market Monitor Global
・発行日:2023年7月
・ページ数:71
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の直接的レニン阻害剤市場規模と予測を収録しています。・世界の直接的レニン阻害剤市場:売上、2018年-2023年、2024年-2029年
・世界の直接的レニン阻害剤市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の直接的レニン阻害剤市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アリスキレン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

直接的レニン阻害剤のグローバル主要企業は、Noden Pharma、 LGM Pharma、 Caymanなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、直接的レニン阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の直接的レニン阻害剤市場:タイプ別、2018年-2023年、2024年-2029年
世界の直接的レニン阻害剤市場:タイプ別市場シェア、2022年
・アリスキレン、レミキレン、その他

世界の直接的レニン阻害剤市場:用途別、2018年-2023年、2024年-2029年
世界の直接的レニン阻害剤市場:用途別市場シェア、2022年
・病院、診療所、その他

世界の直接的レニン阻害剤市場:地域・国別、2018年-2023年、2024年-2029年
世界の直接的レニン阻害剤市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における直接的レニン阻害剤のグローバル売上、2018年-2023年
・主要企業における直接的レニン阻害剤のグローバル売上シェア、2022年
・主要企業における直接的レニン阻害剤のグローバル販売量、2018年-2023年
・主要企業における直接的レニン阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Noden Pharma、 LGM Pharma、 Cayman

*************************************************************

・調査・分析レポートの概要
直接的レニン阻害剤市場の定義
市場セグメント
世界の直接的レニン阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の直接的レニン阻害剤市場規模
世界の直接的レニン阻害剤市場規模:2022年 VS 2029年
世界の直接的レニン阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの直接的レニン阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の直接的レニン阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:アリスキレン、レミキレン、その他
直接的レニン阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、その他
直接的レニン阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別直接的レニン阻害剤市場規模 2022年と2029年
地域別直接的レニン阻害剤売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Noden Pharma、 LGM Pharma、 Cayman
...

Direct renin inhibition is a new means for blocking the renin–angiotensin system at the rate-limiting step of the cascade of events triggered by renin release—the interaction of renin with its physiological substrate angiotensinogen.
This report aims to provide a comprehensive presentation of the global market for Direct Renin Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct Renin Inhibitors. This report contains market size and forecasts of Direct Renin Inhibitors in global, including the following market information:
Global Direct Renin Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Direct Renin Inhibitors Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Direct Renin Inhibitors companies in 2022 (%)
The global Direct Renin Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Aliskiren Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Direct Renin Inhibitors include Noden Pharma, LGM Pharma and Cayman, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Direct Renin Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Direct Renin Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Direct Renin Inhibitors Market Segment Percentages, by Type, 2022 (%)
Aliskiren
Remikiren
Others
Global Direct Renin Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Direct Renin Inhibitors Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Direct Renin Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Direct Renin Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Direct Renin Inhibitors revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Direct Renin Inhibitors revenues share in global market, 2022 (%)
Key companies Direct Renin Inhibitors sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Direct Renin Inhibitors sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Noden Pharma
LGM Pharma
Cayman
Outline of Major Chapters:
Chapter 1: Introduces the definition of Direct Renin Inhibitors, market overview.
Chapter 2: Global Direct Renin Inhibitors market size in revenue and volume.
Chapter 3: Detailed analysis of Direct Renin Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Direct Renin Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Direct Renin Inhibitors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Direct Renin Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Direct Renin Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Direct Renin Inhibitors Overall Market Size
2.1 Global Direct Renin Inhibitors Market Size: 2022 VS 2029
2.2 Global Direct Renin Inhibitors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Direct Renin Inhibitors Sales: 2018-2029
3 Company Landscape
3.1 Top Direct Renin Inhibitors Players in Global Market
3.2 Top Global Direct Renin Inhibitors Companies Ranked by Revenue
3.3 Global Direct Renin Inhibitors Revenue by Companies
3.4 Global Direct Renin Inhibitors Sales by Companies
3.5 Global Direct Renin Inhibitors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Direct Renin Inhibitors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Direct Renin Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Direct Renin Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Direct Renin Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Direct Renin Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Direct Renin Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Aliskiren
4.1.3 Remikiren
4.1.4 Others
4.2 By Type – Global Direct Renin Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Direct Renin Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Direct Renin Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Direct Renin Inhibitors Revenue Market Share, 2018-2029
4.3 By Type – Global Direct Renin Inhibitors Sales & Forecasts
4.3.1 By Type – Global Direct Renin Inhibitors Sales, 2018-2023
4.3.2 By Type – Global Direct Renin Inhibitors Sales, 2024-2029
4.3.3 By Type – Global Direct Renin Inhibitors Sales Market Share, 2018-2029
4.4 By Type – Global Direct Renin Inhibitors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Direct Renin Inhibitors Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Direct Renin Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Direct Renin Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Direct Renin Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Direct Renin Inhibitors Revenue Market Share, 2018-2029
5.3 By Application – Global Direct Renin Inhibitors Sales & Forecasts
5.3.1 By Application – Global Direct Renin Inhibitors Sales, 2018-2023
5.3.2 By Application – Global Direct Renin Inhibitors Sales, 2024-2029
5.3.3 By Application – Global Direct Renin Inhibitors Sales Market Share, 2018-2029
5.4 By Application – Global Direct Renin Inhibitors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Direct Renin Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Direct Renin Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Direct Renin Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Direct Renin Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Direct Renin Inhibitors Revenue Market Share, 2018-2029
6.3 By Region – Global Direct Renin Inhibitors Sales & Forecasts
6.3.1 By Region – Global Direct Renin Inhibitors Sales, 2018-2023
6.3.2 By Region – Global Direct Renin Inhibitors Sales, 2024-2029
6.3.3 By Region – Global Direct Renin Inhibitors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Direct Renin Inhibitors Revenue, 2018-2029
6.4.2 By Country – North America Direct Renin Inhibitors Sales, 2018-2029
6.4.3 US Direct Renin Inhibitors Market Size, 2018-2029
6.4.4 Canada Direct Renin Inhibitors Market Size, 2018-2029
6.4.5 Mexico Direct Renin Inhibitors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Direct Renin Inhibitors Revenue, 2018-2029
6.5.2 By Country – Europe Direct Renin Inhibitors Sales, 2018-2029
6.5.3 Germany Direct Renin Inhibitors Market Size, 2018-2029
6.5.4 France Direct Renin Inhibitors Market Size, 2018-2029
6.5.5 U.K. Direct Renin Inhibitors Market Size, 2018-2029
6.5.6 Italy Direct Renin Inhibitors Market Size, 2018-2029
6.5.7 Russia Direct Renin Inhibitors Market Size, 2018-2029
6.5.8 Nordic Countries Direct Renin Inhibitors Market Size, 2018-2029
6.5.9 Benelux Direct Renin Inhibitors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Direct Renin Inhibitors Revenue, 2018-2029
6.6.2 By Region – Asia Direct Renin Inhibitors Sales, 2018-2029
6.6.3 China Direct Renin Inhibitors Market Size, 2018-2029
6.6.4 Japan Direct Renin Inhibitors Market Size, 2018-2029
6.6.5 South Korea Direct Renin Inhibitors Market Size, 2018-2029
6.6.6 Southeast Asia Direct Renin Inhibitors Market Size, 2018-2029
6.6.7 India Direct Renin Inhibitors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Direct Renin Inhibitors Revenue, 2018-2029
6.7.2 By Country – South America Direct Renin Inhibitors Sales, 2018-2029
6.7.3 Brazil Direct Renin Inhibitors Market Size, 2018-2029
6.7.4 Argentina Direct Renin Inhibitors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Direct Renin Inhibitors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Direct Renin Inhibitors Sales, 2018-2029
6.8.3 Turkey Direct Renin Inhibitors Market Size, 2018-2029
6.8.4 Israel Direct Renin Inhibitors Market Size, 2018-2029
6.8.5 Saudi Arabia Direct Renin Inhibitors Market Size, 2018-2029
6.8.6 UAE Direct Renin Inhibitors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Noden Pharma
7.1.1 Noden Pharma Company Summary
7.1.2 Noden Pharma Business Overview
7.1.3 Noden Pharma Direct Renin Inhibitors Major Product Offerings
7.1.4 Noden Pharma Direct Renin Inhibitors Sales and Revenue in Global (2018-2023)
7.1.5 Noden Pharma Key News & Latest Developments
7.2 LGM Pharma
7.2.1 LGM Pharma Company Summary
7.2.2 LGM Pharma Business Overview
7.2.3 LGM Pharma Direct Renin Inhibitors Major Product Offerings
7.2.4 LGM Pharma Direct Renin Inhibitors Sales and Revenue in Global (2018-2023)
7.2.5 LGM Pharma Key News & Latest Developments
7.3 Cayman
7.3.1 Cayman Company Summary
7.3.2 Cayman Business Overview
7.3.3 Cayman Direct Renin Inhibitors Major Product Offerings
7.3.4 Cayman Direct Renin Inhibitors Sales and Revenue in Global (2018-2023)
7.3.5 Cayman Key News & Latest Developments
8 Global Direct Renin Inhibitors Production Capacity, Analysis
8.1 Global Direct Renin Inhibitors Production Capacity, 2018-2029
8.2 Direct Renin Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Direct Renin Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Direct Renin Inhibitors Supply Chain Analysis
10.1 Direct Renin Inhibitors Industry Value Chain
10.2 Direct Renin Inhibitors Upstream Market
10.3 Direct Renin Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Direct Renin Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Direct Renin Inhibitors in Global Market
Table 2. Top Direct Renin Inhibitors Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Direct Renin Inhibitors Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Direct Renin Inhibitors Revenue Share by Companies, 2018-2023
Table 5. Global Direct Renin Inhibitors Sales by Companies, (K Units), 2018-2023
Table 6. Global Direct Renin Inhibitors Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Direct Renin Inhibitors Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Direct Renin Inhibitors Product Type
Table 9. List of Global Tier 1 Direct Renin Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Direct Renin Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Direct Renin Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Direct Renin Inhibitors Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Direct Renin Inhibitors Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Direct Renin Inhibitors Sales (K Units), 2018-2023
Table 15. By Type - Global Direct Renin Inhibitors Sales (K Units), 2024-2029
Table 16. By Application – Global Direct Renin Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Direct Renin Inhibitors Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Direct Renin Inhibitors Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Direct Renin Inhibitors Sales (K Units), 2018-2023
Table 20. By Application - Global Direct Renin Inhibitors Sales (K Units), 2024-2029
Table 21. By Region – Global Direct Renin Inhibitors Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Direct Renin Inhibitors Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Direct Renin Inhibitors Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Direct Renin Inhibitors Sales (K Units), 2018-2023
Table 25. By Region - Global Direct Renin Inhibitors Sales (K Units), 2024-2029
Table 26. By Country - North America Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Direct Renin Inhibitors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Direct Renin Inhibitors Sales, (K Units), 2018-2023
Table 29. By Country - North America Direct Renin Inhibitors Sales, (K Units), 2024-2029
Table 30. By Country - Europe Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Direct Renin Inhibitors Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Direct Renin Inhibitors Sales, (K Units), 2018-2023
Table 33. By Country - Europe Direct Renin Inhibitors Sales, (K Units), 2024-2029
Table 34. By Region - Asia Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Direct Renin Inhibitors Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Direct Renin Inhibitors Sales, (K Units), 2018-2023
Table 37. By Region - Asia Direct Renin Inhibitors Sales, (K Units), 2024-2029
Table 38. By Country - South America Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Direct Renin Inhibitors Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Direct Renin Inhibitors Sales, (K Units), 2018-2023
Table 41. By Country - South America Direct Renin Inhibitors Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Direct Renin Inhibitors Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Direct Renin Inhibitors Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Direct Renin Inhibitors Sales, (K Units), 2024-2029
Table 46. Noden Pharma Company Summary
Table 47. Noden Pharma Direct Renin Inhibitors Product Offerings
Table 48. Noden Pharma Direct Renin Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Noden Pharma Key News & Latest Developments
Table 50. LGM Pharma Company Summary
Table 51. LGM Pharma Direct Renin Inhibitors Product Offerings
Table 52. LGM Pharma Direct Renin Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. LGM Pharma Key News & Latest Developments
Table 54. Cayman Company Summary
Table 55. Cayman Direct Renin Inhibitors Product Offerings
Table 56. Cayman Direct Renin Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Cayman Key News & Latest Developments
Table 58. Direct Renin Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Direct Renin Inhibitors Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Direct Renin Inhibitors Production by Region, 2018-2023 (K Units)
Table 61. Global Direct Renin Inhibitors Production by Region, 2024-2029 (K Units)
Table 62. Direct Renin Inhibitors Market Opportunities & Trends in Global Market
Table 63. Direct Renin Inhibitors Market Drivers in Global Market
Table 64. Direct Renin Inhibitors Market Restraints in Global Market
Table 65. Direct Renin Inhibitors Raw Materials
Table 66. Direct Renin Inhibitors Raw Materials Suppliers in Global Market
Table 67. Typical Direct Renin Inhibitors Downstream
Table 68. Direct Renin Inhibitors Downstream Clients in Global Market
Table 69. Direct Renin Inhibitors Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Direct Renin Inhibitors Segment by Type in 2022
Figure 2. Direct Renin Inhibitors Segment by Application in 2022
Figure 3. Global Direct Renin Inhibitors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Direct Renin Inhibitors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Direct Renin Inhibitors Revenue, 2018-2029 (US$, Mn)
Figure 7. Direct Renin Inhibitors Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Direct Renin Inhibitors Revenue in 2022
Figure 9. By Type - Global Direct Renin Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 11. By Type - Global Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 12. By Type - Global Direct Renin Inhibitors Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Direct Renin Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 15. By Application - Global Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 16. By Application - Global Direct Renin Inhibitors Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Direct Renin Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Direct Renin Inhibitors Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 20. By Region - Global Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 21. By Country - North America Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 22. By Country - North America Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 23. US Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 28. Germany Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 29. France Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 37. China Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 41. India Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 43. By Country - South America Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 44. Brazil Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Direct Renin Inhibitors Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Direct Renin Inhibitors Sales Market Share, 2018-2029
Figure 48. Turkey Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Direct Renin Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 52. Global Direct Renin Inhibitors Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Direct Renin Inhibitors by Region, 2022 VS 2029
Figure 54. Direct Renin Inhibitors Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の直接的レニン阻害剤市場予測2023-2029:アリスキレン、レミキレン、その他] (コード:MMG23LY8470)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の直接的レニン阻害剤市場予測2023-2029:アリスキレン、レミキレン、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆